Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Amortizatization of Intangibles (2022 - 2025)

Terns Pharmaceuticals filings provide 4 years of Amortizatization of Intangibles readings, the most recent being $101000.0 for Q4 2025.

  • Quarterly Amortizatization of Intangibles fell 31.76% to $101000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $411000.0 through Dec 2025, down 28.77% year-over-year, with the annual reading at $411000.0 for FY2025, 28.77% down from the prior year.
  • Amortizatization of Intangibles hit $101000.0 in Q4 2025 for Terns Pharmaceuticals, up from $99000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $154000.0 in Q1 2024 and bottomed at $97000.0 in Q2 2025.
  • Average Amortizatization of Intangibles over 4 years is $132812.5, with a median of $140000.0 recorded in 2022.
  • The largest annual shift saw Amortizatization of Intangibles grew 10.69% in 2023 before it plummeted 36.18% in 2025.
  • Terns Pharmaceuticals' Amortizatization of Intangibles stood at $140000.0 in 2022, then rose by 5.71% to $148000.0 in 2023, then changed by 0.0% to $148000.0 in 2024, then tumbled by 31.76% to $101000.0 in 2025.
  • Per Business Quant, the three most recent readings for TERN's Amortizatization of Intangibles are $101000.0 (Q4 2025), $99000.0 (Q3 2025), and $97000.0 (Q2 2025).